U.S. markets closed
  • S&P Futures

    3,292.00
    +28.50 (+0.87%)
     
  • Dow Futures

    26,637.00
    +228.00 (+0.86%)
     
  • Nasdaq Futures

    11,227.25
    +94.50 (+0.85%)
     
  • Russell 2000 Futures

    1,550.40
    +11.20 (+0.73%)
     
  • Crude Oil

    37.59
    +0.20 (+0.53%)
     
  • Gold

    1,877.60
    -1.60 (-0.09%)
     
  • Silver

    23.39
    +0.03 (+0.11%)
     
  • EUR/USD

    1.1759
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • Vix

    40.28
    +6.93 (+20.78%)
     
  • GBP/USD

    1.2994
    +0.0007 (+0.05%)
     
  • USD/JPY

    104.4370
    +0.1360 (+0.13%)
     
  • BTC-USD

    13,234.14
    +16.85 (+0.13%)
     
  • CMC Crypto 200

    261.91
    -10.78 (-3.95%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,246.62
    -171.89 (-0.73%)
     

The Zacks Analyst Blog Highlights: AstraZeneca, BioNTech, Pfizer, Cimarex Energy, Diamondback Energy, Centennial Resource Development and Bonanza Creek Energy

Zacks Equity Research
·5 mins read

For Immediate Release

Chicago, IL – July 23, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AstraZeneca PLC AZN, BioNTech SE BNTX, Pfizer Inc. PFE, Cimarex Energy Co. XEC, Diamondback Energy, Inc. FANG, Centennial Resource Development, Inc. CDEV and Bonanza Creek Energy, Inc. BCEI.

Here are highlights from Wednesday’s Analyst Blog:

Tap the Crude Oil Rally with These 4 Energy Stocks

Oil energy stocks climbed higher after the European Union’s (EU) fiscal stimulus package raised optimism for the bloc to overcome the coronavirus pandemic’s economic fallout. Oil prices rallied to their highest level since early March, when the commodity was trading in bearish territory following the pricing war between Russia and Saudi Arabia.

European Union Stimulus Deal

To safeguard EU economies that have been hit hard by the coronavirus pandemic, European leaders have decided to create a recovery fund of roughly €750 billion following five days of discussions.

The EU will tap the financial market to borrow the amount. Of the total recovery fund, €390 billion will be distributed to severely hit EU member states as grants. The remaining fund will be distributed as loans. The agreement also comprises a fresh budget of roughly €1.1 trillion for 2021 to 2027, thereby creating a combined spending package of €1.8 trillion.

Coronavirus Vaccine Hopes

There has been growing optimism surrounding the development of a coronavirus vaccine by 2020-end after three of the leading candidates in the world recently reported promising early trial data. The studies established that the three vaccine candidates have generated sufficient immune responses. Also, no serious side effects were reported by the participants through the study period, signifying that the vaccines were well tolerated and safe.

One of the three promising vaccine candidates is being developed by the Oxford University researchers and AstraZeneca PLC. The other two are experimental vaccines of German biotech firm BioNTech SE and U.S. drugmaker Pfizer Inc.; and China’s CanSino Biologics.

EU Deal & Vaccine Hopes Lift Oil

The news of the EU stimulus deal and advancement of coronavirus studies have made investors more hopeful that fuel demand will improve following the gradual recovery of global economies. On Jul 21, the price of crude oil rallied to a four-month high, buoyed by the positive news.

The price of West Texas Intermediate (WTI) crude surged 3.3% to touch $42.17 per barrel mark, the highest since Mar 6. The price of Brent crude also surged 3.2% to $44.67 per barrel, the highest since early March.

Stocks Poised to Gain

The surge in oil price, recovering more than 230% since late-April, is supportive of upstream energy operations. Hence, it will be wise for investors to consider upstream energy stocks with oil contributing majorly to production volumes. We have shortlisted four stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Cimarex Energy Co. is among the leading energy firms with a strong footprint in the Permian, the most prolific basin in the United States. The company, with oil contributing significantly to its total production volumes, has witnessed upward estimate revisions for 2020 bottom line in the past 30 days. Notably, the Zacks Rank #2 stock gained 10.9% on Jul 21 following the news of the EU stimulus deal.

Diamondback Energy, Inc., being engaged in exploiting and developing unconventional onshore oil reserves in the Permian, is also a leading energy player. The Zacks #2 Ranked company has also witnessed upward earnings estimate revisions for 2020 in the past 30 days. The stock gained 9.2% on the day.

Centennial Resource Development, Inc. also has a strong footprint in the Delaware Basin, a sub-basin of the Permian Basin. In the past 60 days, the oil producer with a Zacks Rank of 2 has seen upward estimate revisions for 2020 bottom line. The stock gained 12.5% on Jul 21.

Bonanza Creek Energy, Inc. is a leading oil producer in the domestic market. The #1 Ranked stock has seen upward earnings estimate revisions for 2020 in the past 30 days. The company also gained 8.3% on Jul 21.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that have beaten the market more than 2X over with a stunning average gain of +24.1% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                             

https://www.zacks.com                                        

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AstraZeneca PLC (AZN) : Free Stock Analysis Report
 
Pfizer Inc. (PFE) : Free Stock Analysis Report
 
Cimarex Energy Co (XEC) : Free Stock Analysis Report
 
Diamondback Energy, Inc. (FANG) : Free Stock Analysis Report
 
Bonanza Creek Energy, Inc. (BCEI) : Free Stock Analysis Report
 
CENTENNIAL RES (CDEV) : Free Stock Analysis Report
 
BioNTech SE Sponsored ADR (BNTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.